财经今日头条 > 财经 > 财经要闻

康泰生物重组腺病毒载体新冠疫苗在印尼获批作为同源加强针

财经要闻 2022-01-11 22:29:11
在当前的奥密克戎浪潮中,美国因新冠入院治疗的儿童人数一直在上升,特别是五岁以下住院的新冠患者人数一直在增加。美国疾病控制和预防中心的新冠相关住院监测网络数据估计,每100000名0-4岁儿童中有5.3人因新冠住院,是去年11月下旬的两倍多。年龄较大儿童住院情况与去年年夏末和秋季的德尔塔浪潮相似。到目前为止,美国尚未建议五岁以下的儿童接种新冠疫苗。","multimedia":{"img_url":["https://n.sinaimg.cn/zhibo/4/w1292h1112/20220111/c03f-2266c0abed2815259d342630d888ff9a.png"]},"commentid":"live:finance-152-2485524:0","compere_id":0,"creator":"qiqi7@staff.sina.com.cn","mender":"qiqi7@staff.sina.com.cn","create_time":"2022-01-11 22:29:25","update_time":"2022-01-11 22:29:31","is_need_check":"1","check_time":"2022-01-11 22:29:28","check_status":"1","check_user":"yongsheng6@staff.sina.com.cn","is_delete":0,"top_value":0,"is_focus":0,"source_content_id":"0","anchor_image_url":"","anchor":"直播员","ext":"{"stocks":[],"needPush":false,"needAIPush":false,"needCMSLink":true,"needCalender":false,"needProvince":"0","docurl":"https:\/\/finance.sina.com.cn\/7x24\/2022-01-11\/doc-ikyakumx9774412.shtml","docid":"kyakumx9774412"}","old_live_cid":"0","tag":[{"id":"102","name":"国际"}],"like_nums":0,"comment_list":{"list":[],"total":0,"thread_show":0,"qreply":0,"qreply_show":0,"show":0},"docurl":"https://finance.sina.cn/7x24/2022-01-11/detail-ikyakumx9774412.d.html","rich_text_nick_to_url":[],"compere_info":""},{"id":2485523,"zhibo_id":152,"type":0,"rich_text":"【康泰生物重组腺病毒载体新冠疫苗在印尼获批作为同源加强针】日前,印尼药物与食品监管局(BPOM)授予康泰生物生产的重组腺病毒载体新冠疫苗Kconecavac作为同源加强针的紧急使用授权。

本文系网络转载,不代表本站立场。

财经今日头条

http://www.cuiru123.com

统计代码 | 京ICP133291237-2号

Powered By 财经今日头条

股票

股市行情

炒股入门

股票知识

期货

期货新闻

期货知识

期货行情

财经

财经要闻

观点评论

民生消费

基金

基金动态

基金行情

基金视点